Accelitech Partners with St. Francis Hospital to Bring CyberKnife Center to Memphis
CHICAGO, May 22, 2012 /PRNewswire/ — Accelitech LLC, a leading private developer of advanced cancer treatment centers in the United States, is pleased to announce a partnership agreement with St. Francis Hospital in Memphis, TN. Accelitech and St. Francis will develop a CyberKnife center, where patients from Memphis and throughout the mid south will be able to receive pain-free, non-invasive treatment for a variety of cancers, including prostate, pancreas, brain and lung. The Memphis center will be Accelitech’s ninth CyberKnife location and eleventh technology center in total.
“Our goal with this and every joint-venture partnership is to bring new technology to patients who need it most,” says Kerwin Brandt, CEO of Accelitech. “We’re very excited to move forward with St. Francis and to add a Memphis location to our rapidly growing network of CyberKnife centers.”
Hospitals interested in learning more about the ways Accelitech can help them own and deliver cutting-edge treatment technology may visit accelitech.biz or call (773) 850-3300 for more information.
About Accelitech LLC
Accelitech LLC is a leader in the development and full-cycle management of technology-driven cancer treatment programs nationwide. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. A vendor-neutral company with centers offering technology from Accuray, Varian Medical Systems, Brainlab and others, Accelitech has sites in operation and development throughout the United States and Europe. For additional information about Accelitech and its services, please visit accelitech.biz.
CyberKnife by Accuray is the first and only robotic radiosurgery system delivering customizable, non-surgical treatments for a broad range of tumors anywhere in the body. Only the CyberKnife system allows practitioners to non-invasively deliver high doses of radiation to tumors with extreme accuracy and intense precision, providing personalized and tailored treatments that help clinicians pursue the best clinical outcomes for patients’ individual needs. For more information on CyberKnife, please visit accuray.com.
Media Contact: Stacey@beecommunications.com
SOURCE Accelitech LLC